Literature DB >> 9872348

Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis.

C Hanck1, S Rossol, U Böcker, M Tokus, M V Singer.   

Abstract

Cytokines and plasma endotoxin were measured in a consecutive series of patients with alcoholic cirrhosis (AC). Endotoxaemia was found to be strongly correlated to increased plasma levels of functionally active tumour necrosis factor (TNF) receptors -p55 and -p75, TNF-alpha and the Child-Pugh stage of the disease. Our data support the hypothesis of the pathogenic role of lipopolysaccharide in hepatocellular damage of patients with AC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872348     DOI: 10.1093/alcalc/33.6.606

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  26 in total

1.  Estrogen suppresses heptatic IκB expression during short-term alcohol exposure.

Authors:  Eric G Lee; Bethany M Mickle-Kawar; Lester A Reinke; Randle M Gallucci
Journal:  Inflamm Res       Date:  2012-06-06       Impact factor: 4.575

2.  Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program.

Authors:  Irina A Kirpich; Craig J McClain; Vatsalya Vatsalya; Melanie Schwandt; Monte Phillips; Keith Cameron Falkner; Lucy Zhang; Catey Harwell; David T George; John C Umhau
Journal:  Alcohol Clin Exp Res       Date:  2017-03-02       Impact factor: 3.455

3.  Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis.

Authors:  C Hanck; T Manigold; U Böcker; M Kurimoto; C B Kölbel; M V Singer; S Rossol
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 4.  Alcoholic liver disease: mechanisms of injury and targeted treatment.

Authors:  Alexandre Louvet; Philippe Mathurin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

Review 5.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

6.  Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

Authors:  R P Mookerjee; S Sen; N A Davies; S J Hodges; R Williams; R Jalan
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

7.  Elevated endotoxin levels in non-alcoholic fatty liver disease.

Authors:  Alison L Harte; Nancy F da Silva; Steven J Creely; Kirsty C McGee; Thomas Billyard; Elham M Youssef-Elabd; Gyanendra Tripathi; Esmat Ashour; Mohga S Abdalla; Hayat M Sharada; Ashraf I Amin; Alastair D Burt; Sudhesh Kumar; Christopher P Day; Philip G McTernan
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

Review 8.  Current understanding of osteoporosis associated with liver disease.

Authors:  Inaam A Nakchbandi; Schalk W van der Merwe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

9.  Effect of JIANPI HUOXUE decoction on inflammatory cytokine secretion pathway in rat liver with lipopolysaccharide challenge.

Authors:  Jing-Hua Peng; Yi-Yang Hu; Yang Cheng; Chong Han; Li-Li Xu; Qin Feng; Shao-Dong Chen; Qing Tao; Hong-Shan Li; Xue-Mei Li
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

10.  Nutrition intervention: a strategy against systemic inflammatory syndrome.

Authors:  Helieh S Oz; Theresa S Chen; Manuela Neuman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-04-14       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.